Bellevue Healthcare Trust plc
BBH.L · LSE
11/30/2024 | 11/30/2023 | 11/30/2022 | 11/30/2021 | |
|---|---|---|---|---|
| Revenue | -£150 | £43 | £106 | £170 |
| % Growth | -445.1% | -58.9% | -38% | – |
| Cost of Goods Sold | £6 | £8 | £10 | £10 |
| Gross Profit | -£156 | £35 | £96 | £161 |
| % Margin | 104.3% | 81.6% | 90.9% | 94.2% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £1 | £1 | £1 | £1 |
| SG&A Expenses | £1 | £1 | £1 | £1 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £1 | £0 | £0 |
| Operating Expenses | £1 | £2 | £1 | £1 |
| Operating Income | £77 | -£116 | -£28 | £92 |
| % Margin | -51.3% | -267.1% | -26.7% | 54.1% |
| Other Income/Exp. Net | -£3 | -£5 | -£13 | -£4 |
| Pre-Tax Income | £74 | -£121 | -£41 | £88 |
| Tax Expense | £0 | £0 | £0 | £1 |
| Net Income | £74 | -£121 | -£41 | £87 |
| % Margin | -49.2% | -278.6% | -39.2% | 51.2% |
| EPS | 0.16 | -0.22 | -0.091 | 0.17 |
| % Growth | 172.7% | -141.5% | -153.6% | – |
| EPS Diluted | 0.16 | -0.22 | -0.091 | 0.17 |
| Weighted Avg Shares Out | 459 | 549 | 455 | 510 |
| Weighted Avg Shares Out Dil | 459 | 549 | 455 | 510 |
| Supplemental Information | – | – | – | – |
| Interest Income | £2 | £2 | £0 | £0 |
| Interest Expense | £2 | £4 | £3 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | £77 | -£116 | -£28 | £92 |
| % Margin | -51.3% | -267.1% | -26.7% | 54.1% |